{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:16:40Z","timestamp":1788376600929,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10067-022-06404-8","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T03:04:37Z","timestamp":1667012677000},"page":"703-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3101-040X","authenticated-orcid":false,"given":"Ruoming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenWen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"6404_CR1","doi-asserted-by":"crossref","unstructured":"Mahler M, Miller F, Fritzler M (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review [J]. Autoimmunity Rev 13(0):367\u2013371","DOI":"10.1016\/j.autrev.2014.01.022"},{"issue":"3","key":"6404_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","volume":"70","author":"A Imbert-Masseau","year":"2003","unstructured":"Imbert-Masseau A, Hamidou M, Agard C et al (2003) Antisynthetase syndrome [J]. Joint Bone Spine 70(3):161\u2013168","journal-title":"Joint Bone Spine"},{"issue":"1","key":"6404_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A et al (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy [J]. Clin Rev Allergy Immunol 52(1):11\u201319","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"6404_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"N McHugh","year":"2018","unstructured":"McHugh N, Tansley S (2018) Autoantibodies in myositis [J]. Nat Rev Rheumatol 14(5):290\u2013302","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"6404_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","volume":"23","author":"L Witt","year":"2016","unstructured":"Witt L, Curran J, Strek M (2016) The diagnosis and treatment of antisynthetase syndrome [J]. Clin Pulm Med 23(5):218\u2013226","journal-title":"Clin Pulm Med"},{"issue":"6","key":"6404_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"W Travis","year":"2013","unstructured":"Travis W, Costabel U, Hansell D et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias [J]. Am J Respir Crit Care Med 188(6):733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"6404_CR7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T et al (2010) Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis [J]. Rheumatology (Oxford) 49(9):1713\u20131719","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6404_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12890-021-01399-5","volume":"21","author":"X Zhan","year":"2021","unstructured":"Zhan X, Yan W, Wang Y et al (2021) Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China [J]. BMC Pulm Med 21(1):57\u201361","journal-title":"BMC Pulm Med"},{"issue":"7","key":"6404_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Li S, Yang H et al (2017) Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies [J]. J Rheumatol 44(7):1051\u20131057","journal-title":"J Rheumatol"},{"issue":"3","key":"6404_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/08916930600623791","volume":"39","author":"R La Corte","year":"2006","unstructured":"La Corte R, Lo Mo naco A, Locaputo A et al (2006) In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease [J]. Autoimmunity 39(3):249\u2013253","journal-title":"Autoimmunity"},{"issue":"9","key":"6404_CR11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","volume":"29","author":"A V\u00e1ncsa","year":"2009","unstructured":"V\u00e1ncsa A, Cs\u00edpo I, N\u00e9meth J et al (2009) Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients [J]. Rheumatol Int 29(9):989\u2013994","journal-title":"Rheumatol Int"},{"key":"6404_CR12","unstructured":"Cavagna L, Trallero-Aragu\u00e1s E, Meloni F et al (2019) Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course [J]. J Clin Med 8(11)"},{"issue":"1","key":"6404_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N et al (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients [J]. Ann Rheum Dis 73(1):227\u2013232","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6404_CR14","first-page":"150","volume":"27","author":"R Kumar","year":"2021","unstructured":"Kumar R, Jha S, Dhooria A et al (2021) Anti-Jo-1 syndrome often misdiagnosed as rheumatoid arthritis (for many years): a single-center experience [J]. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 27(4):150\u2013155","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"6","key":"6404_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3899\/jrheum.151067","volume":"43","author":"H Andersson","year":"2016","unstructured":"Andersson H, Aal\u00f8kken T, G\u00fcnther A et al (2016) Pulmonary involvement in the antisynthetase syndrome: a comparative cross-sectional Study [J]. J Rheumatol 43(6):1107\u20131113","journal-title":"J Rheumatol"},{"issue":"10","key":"6404_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","volume":"108","author":"C Johnson","year":"2014","unstructured":"Johnson C, Connors G, Oaks J et al (2014) Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type [J]. Respir Med 108(10):1542\u20131548","journal-title":"Respir Med"},{"issue":"6","key":"6404_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/BOR.0000000000000663","volume":"31","author":"M Gasparotto","year":"2019","unstructured":"Gasparotto M, Gatto M, Saccon F et al (2019) Pulmonary involvement in antisynthetase syndrome [J]. Curr Opin Rheumatol 31(6):603\u2013610","journal-title":"Curr Opin Rheumatol"},{"key":"6404_CR18","doi-asserted-by":"crossref","unstructured":"Chen F, Zuo Y, Li S et al (2019) Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: data from the largest single Chinese center [J]. Respir Med 155:127\u2013132","DOI":"10.1016\/j.rmed.2019.07.020"},{"issue":"6","key":"6404_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","volume":"56","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Huapaya J et al (2017) A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies [J]. Rheumatology (Oxford) 56(6):999\u20131007","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"6404_CR20","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s10067-020-04979-8","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ge Y, Yang H et al (2020) Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome [J]. Clin Rheumatol 39(8):2417\u20132419","journal-title":"Clin Rheumatol"},{"issue":"6","key":"6404_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","volume":"41","author":"I Marie","year":"2012","unstructured":"Marie I, Hatron P, Dominique S et al (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody [J]. Semin Arthritis Rheum 41(6):890\u2013899","journal-title":"Semin Arthritis Rheum"},{"key":"6404_CR22","doi-asserted-by":"crossref","unstructured":"Shao C, Sun Y, Huang H et al (2021) Myositis specific antibodies are associated with isolated anti-Ro-52 associated interstitial lung disease [J]. Rheumatology (Oxford, England) 61(3):1083\u20131091","DOI":"10.1093\/rheumatology\/keab488"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06404-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T04:07:21Z","timestamp":1676520441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06404-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6404"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06404-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was waived by the IRB (Institutional Review Board) of Tianjin Medical University General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}